Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Pathology | Journal

Back to Journal Articles

Fibroblasts Reprogrammed Into Functioning Heart Cells in Mice

Last Updated: April 20, 2012.

 

In vivo delivery of GMT genes cuts infarct size, reduces cardiac dysfunction after coronary ligation

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Cells that normally form scar tissue after a heart attack can be reprogrammed into functional heart cells in mice, according to an experimental study published online April 18 in Nature.

FRIDAY, April 20 (HealthDay News) -- Cells that normally form scar tissue after a heart attack can be reprogrammed into functional heart cells in mice, according to an experimental study published online April 18 in Nature.

Noting that cardiac fibroblasts can be reprogrammed in vitro to become adult cardiomyocyte-like cells through the addition of the Gata4, Mef2c, and Tbx5 (GMT) genes, Li Qian, Ph.D., from the University of California in San Francisco, and colleagues examined whether this could also be done in vivo by adding these genes to cardiac non-myocytes (mostly fibroblasts) in the hearts of mice after coronary ligation.

The researchers found that, within a month, the induced cells resembled cardiomyocytes: they became binucleate, assembled sarcomeres, and had gene-expression similar to cardiomyocytes. On single-cell analysis, ventricular action potentials like those of cardiomyocytes were noted, as were beating after electrical stimulation and evidence of electrical coupling. Up to three months after coronary ligation, infarct size was reduced and cardiac function improved following in vivo delivery of GMT. Delivery of thymosin beta-4, a pro-angiogenic and fibroblast-activating peptide, led to further improvements in scar area and cardiac function.

"These findings demonstrate that cardiac fibroblasts can be reprogrammed into cardiomyocyte-like cells in their native environment for potential regenerative purposes," Qian and colleagues conclude.

One author is a member of the scientific advisory boards for iPierian Inc. and RegeneRx Biopharmaceuticals.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Patient-Centered Approach Key for T2DM Management Next: Novel Balanced Chromosome Abnormalities Found in Autism

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.